Breaking: Vinay Prasad tapped to run FDA center that regulates vaccines, gene therapies

Prasad is replacing former CBER director Peter Marks, who was forced to resign by health secretary Robert F. Kennedy, Jr.

Log In    Subscribe BREAKING NEWS   Vinay Prasad tapped to run FDA center that regulates vaccines, gene therapies By Lizzy Lawrence, Matthew Herper, and Jason Mast Amanda Lucier for STAT Vinay Prasad will be the next director of the Center for Biologics Evaluation and Research at the Food and Drug Administration, overseeing the regulation of vaccines, gene therapies, and the blood supply.    Prasad, previously an epidemiology professor at the University of California at San Francisco, has sharply criticized the medical mainstream, including the FDA, in the past. Prasad is replacing former CBER director Peter Marks, who was forced to resign by health secretary Robert F. Kennedy Jr. in March. READ MORE Sign up for D.C. Diagnosis The latest updates in federal health agencies, research institutes, and U.S. policy. Learn more. In Case You Missed It 1   Exclusive: Overseas grants could be 'closed down' by NIH under new policy, internal email suggests By Megan Molteni 2   A proudly frugal tech CEO now runs Medicare, where he'll hunt for savings on a far bigger stage By Mario Aguilar 3   A running list of senior FDA officials who have left the agency By Lizzy Lawrence and J. Emory Parker 4   Scientists question NIH project's use of 20th century technology to make a universal flu vaccine Helen Branswell Get your first 3 months for $30 Unlock access to STAT's award-winning journalism, premium data tools, and must-read, subscriber-only newsletters.  Subscribe STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us